Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Isolyte S (Multi-Electrolyte Injection) is an FDA-approved intravenous solution developed by B. Braun Medical Inc. It is a sterile, nonpyrogenic multi-electrolyte solution containing magnesium chloride, potassium chloride, sodium acetate, sodium chloride, and sodium gluconate. Indicated for use in both adult and pediatric patients, it serves as a source of electrolytes and water for hydration and acts as an alkalinizing agent. The solution's electrolyte composition is designed to support various physiological functions: sodium regulates water distribution and osmotic pressure; potassium is essential for nerve conduction and muscle contraction; magnesium acts as a cofactor for numerous intracellular enzymatic reactions; and chloride, acetate, and gluconate contribute to maintaining acid-base balance. The acetate and gluconate components are metabolized to bicarbonate, providing the solution's alkalinizing effect.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on magnesium chloride + sodium acetate + potassium chloride + sodium gluconate + sodium chloride.